Literature DB >> 6324823

A murine model of polymyositis induced by coxsackievirus B1 (Tucson strain).

S L Strongwater, K Dorovini-Zis, R D Ball, T J Schnitzer.   

Abstract

A murine model of polymyositis induced by coxsackievirus B1, Tucson strain (CVBT) is described. Intraperitoneal CVBT inoculation of CD 1 Swiss mice less than 48 hours old resulted in proximal hindquarter weakness that was first apparent 7 days after viral challenge and persisted for more than 10 weeks. Electromyographic and histologic evidence of a continuing myositis was present during this entire period of time. However, virus was not detectable later than 2 weeks post infection, despite clinical progression of disease. The finding of electromyographic and histologic abnormalities in CVBT-infected mice, long after virus had cleared and neutralizing antibody production evoked, suggests that persistent myositis may be immunologically mediated, triggered by the initial acute viral infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324823     DOI: 10.1002/art.1780270411

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  Higher eukaryotic aminoacyl-tRNA synthetases in physiologic and pathologic states.

Authors:  C V Dang; C V Dang
Journal:  Mol Cell Biochem       Date:  1986-08       Impact factor: 3.396

Review 2.  Triggers of inflammatory myopathy: insights into pathogenesis.

Authors:  Brittany L Adler; Lisa Christopher-Stine
Journal:  Discov Med       Date:  2018-02       Impact factor: 2.970

3.  Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu/nu mice.

Authors:  S R Ytterberg; M L Mahowald; R P Messner
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution.

Authors:  P E Tam; R P Messner
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Molecular determinants for virulence in coxsackievirus B1 infection.

Authors:  J E Rinehart; R M Gómez; R P Roos
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis.

Authors:  G E Yousef; D A Isenberg; J F Mowbray
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

7.  Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.

Authors:  Patricia E Tam; Melissa L Weber-Sanders; Ronald P Messner
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease.

Authors:  I N Targoff; F C Arnett; L Berman; C O'Brien; M Reichlin
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

9.  Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle.

Authors:  P J Jongen; G J Zoll; M Beaumont; W J Melchers; L B van de Putte; J M Galama
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

10.  Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis.

Authors:  P E Tam; A M Schmidt; S R Ytterberg; R P Messner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.